Introduction
Liposomal gene transfer of cDNA coding for growth factors was shown to be effective in accelerating reepithelization, increase local growth factors and neoangiogenesis. [1] [2] [3] [4] In acute dermal and epidermal wounds, liposomal gene transfer of genes coding for growth factors was shown effective in improving dermal and epidermal regeneration. 1, [5] [6] [7] Therefore, we used the physiologic cascade of wound healing as a model to investigate the effect of non-viral liposomal gene transfer. Among many growth factors that may play role during the wound healing cascade, only few growth factors were delivered by liposomal gene transfer. Sun et al. 7 administered acidic fibroblast growth factor (aFGF) and showed improved wound healing, Nakamura et al. 8 administered liposomal platelet derived growth factor (PDGF) cDNA and showed improved ligamental healing. Our group investigated the effect of liposomaldelivered insulin-like growth factor-I (IGF-I) cDNA and keratinocyte growth factor (KGF) cDNA on dermal and epidermal regeneration. 5, [9] [10] [11] All these growth factors when given individually were shown to improve wound healing, collagen or skin breaking strength, skin quality or dermal and epidermal regeneration 5, [7] [8] [9] [10] [11] However, given the complexity and the many factors involved in the cascade a monotherapy may not be sufficient. Therefore, we performed a study in rodents in which we gave the combination of two genes KGF and IGF-I. 12 We found that the combination of the two genes was advantageous over monotherapy in terms of wound healing but we did not determine by which mechanisms IGF-I plus KGF improved epidermal regeneration. Therefore, the aim of the present study was to determine the cellular and physiologic mechanisms by which the combination of IGF-I and KGF improve dermal and epidermal regeneration.
Results

Re-epithelization
Confirming previous experiments, wound healing in terms of re-epithelization was significantly increased (Po0. 05) in rats receiving the IGF-I cDNA, KGF cDNA and the combination of IGF-I plus KGF cDNA 33 days after wounding when compared with rats receiving the liposomes alone ( Figure 1 ). However, rats receiving the combination of IGF-I and KGF had significantly increased (Po0.05) re-epithelization compared to IGF-I and KGF cDNA alone (Figure 1 ).
Collagen types I, III and IV
Expression of collagen type I was increased at the wound edge and under the wound bed compared to normal skin ( Figure 2a ). There were no significant differences between rats receiving the IGF-I, KGF or IGF-I plus KGF cDNA and rats receiving liposomes in collagen type I expression in normal skin, at the wound edge or under the wound bed (Figure 2a) .
Collagen type III expression showed a similar pattern as collagen type I. Increased expression was found at the wound edge and under the wound bed. IGF-I cDNA, KGF cDNA or the combination did not have any effect on collagen type III expression in normal skin, at the wound edge or under the wound bed when compared to liposomes (Figure 2b) .
Collagen type IV expression showed the highest expression at the wound edge and at the wound bed in the four groups. IGF-I cDNA, KGF cDNA and IGF-I plus KGF cDNA increased (Po0.05) collagen type IV expression at the area of non-injured skin, wound edge and under the wound bed when compared with control animals (Figure 2c ). Expression of collagen type IV was similar in IGF-I, KGF and IGF-I plus KGF cDNA groups.
Growth factors IGF-I, PDGF, FGF, FGF-7, TGF-b and VEGF PDGF showed greater expression at the wound edge and under the wound bed compared to the normal skin (Figure 3a) . IGF-I, KGF and IGF-I plus KGF cDNA gene transfer had no effect on PDGF expression 33 days after wounding compared to controls (Figure 3a) .
Positive staining for bFGF and thus bFGF expression was high at the wound edge and under the wound bed compared to normal skin. Liposomal IGF-I, KGF and IGF-I plus KGF cDNA gene transfer increased (Po0.05) bFGF expression compared to controls (Figure 3b) .
Transforming growth factor-b (TGF-b) expression was lowest at the non-injured skin site. TGF-b increased at the wound edge and under the wound bed (Figure 3c ). IGF-I, KGF and IGF-I plus KGF cDNA did not have any effect on skin TGF-b expression. Insulin like growth factor binding protein-3 (IGFBP-3) expression was similar to the IGF-I expression. IGFBP-3 was lowest in the dermis of the non-injured skin, increased towards the wound edge and had its highest expression under the wound bed (Figure 3e ). IGF-I cDNA gene transfer increased (Po0.05) IGFBP-3 expression at the non-injured skin site and at the wound bed compared to liposomes (Figure 3e ). KGF cDNA increased (Po0.05) IGFBP-3 protein expression at the wound edge and under the wound bed compared to controls (Figure 3e ). IGF-I plus KGF cDNA increased (Po0.05) skin IGFBP-3 at the non-injured wound site, the wound edge and under the wound bed when compared to liposomes (Figure 3e ). Expression of IGFBP-3 was similar in the IGF-I, KGF and IGF-I plus KGF cDNA groups.
KGF skin expression was low at the non-injured skin area. KGF increased towards the wound edge and the wound bed. IGF-I, KGF and IGF-I plus KGF cDNA gene transfer increased (Po0.05) KGF protein expression at the wound edge and under the wound bed in the skin (Figure 3f ). There was no significant difference between the cDNA groups in KGF expression.
Neoangiogenesis
IGF-I plus KGF cDNA treatment increased the number of blood vessels per HPF, and thus neoangiogenesis, Po0.05 (Figure 4a ). IGF-I and KGF cDNA had significantly more (Po0.05) blood vessels compared to liposomes, but IGF-I plus KGF cDNA had significantly more (Po0.05) blood vessels compared to the other three groups.
Increased neovascularization was associated with increased vascular endothelial growth factor (VEGF) expression. Generally, VEGF was mainly expressed at the wound edge and under the wound bed with very low expression in the uninjured skin ( Figure 4b ). IGF-I cDNA and KGF cDNA alone increased (Po0.05) VEGF protein expression at the wound edge and under the wound bed compared to liposomes (Figure 4b ). Rats receiving the combination of IGF-I plus KGF cDNA had significantly greater (Po0.05) VEGF expression when compared to the other three groups at the wound edge and under the wound bed (Figure 4b ).
Discussion
The present study investigated by which mechanisms the administration of multiple cDNAs improves dermal and epidermal regeneration. Liposomal transfer of KGF and IGF-I cDNA had additive effects when compared to the administration of the same growth factors individually. IGF-I plus KGF cDNA transfer resulted in accelerated re-epithelization and epidermal regeneration. Since only neovascularization and VEGF expression were increased by applied treatments, we suggest that IGF-I plus KGF cDNA improved dermal and epidermal regeneration via these two mechanisms. The importance of this finding is that VEGF and neovascularization may play a more central role then previously thought and that VEGF cDNA gene transfer should be included in further studies.
Vascular supply of the wound is essential for wound healing and reliant on neovascularization. During wound healing, angiogenic capillary sprouts invade the fibrin/fibronectin-rich wound and within a few days organize into a microvascular network in the granulation tissue. 13 Neovascularization depends on a dynamic interaction between endothelial cells, cytokines and the extracellular matrix.
14 VEGF stimulates and increases neovascularization. 14 Chronic wounds or impaired wounds have decreased expressions of VEGF and fewer blood vessel in the granulation tissue when compared with physiologic wounds, which is probably due to increased proteolysis of VEGF. 15 We found that IGF-I, KGF and the combination of IGF-I plus KGF cDNA transfer increased the number of newly formed blood IGF-I/KGF cDNA increases neovascularization MG Jeschke and DN Herndon vessels in the granulation tissue, which is associated with increased VEGF expression. Multiple cDNA transfer increased VEGF expression in the wound, which in turn leads to increased neoangiogenesis. In preliminary studies, we found that exogenous IGF-I cDNA liposomal gene transfer results in increased IGF-I mRNA and local IGF-I protein expressions, with a concomitant change of IGFBP-1 and IGFBP-3.
5,9 These findings indicate that exogenous IGF-I cDNA gene transfer causes similar cellular and physiologic responses as endogenous IGF-I, which led us to hypothesize that the exogenous transferred gene is recognized by the cell and initiate the same molecular cascade. This is probably the reason why IGF-I cDNA gene transfer is safe and efficacious in improving dermal and epidermal regeneration. In further studies, we showed that the administration of the IGF-I cDNA gene is not the only positive growth factor that results in better wound healing. KGF cDNA transfer also led to better and faster wound healing in acute wounds. 10 KGF is synthesized by several mesenchymal cells, such as fibroblasts, micro-vascular endothelial cells and smooth muscle cells. [16] [17] [18] For KGF to exert its effects, which is mainly in a paracrine fashion, it needs to bind to its receptor FGFR2-IIIb, which is expressed in keratinocytes and hair follicles. 17, 19 Activating the KGF receptor leads, through phosphorylation, to proliferation of epithelial cells and is responsible for the morphogenesis of the skin and thus plays an important role during wound healing. 17, 19 After wounding, KGF protein and mRNA expression increases and they are mainly present in the dermal fibroblasts below the wound and at the wound edges, whereas KGF receptor transcripts and also the corresponding protein were exclusively detected in keratinocytes of the epidermis and the hair follicles. 17, 19 These cells migrate over the wound and subsequently proliferate, which leads to complete wound re-epithelization. Conforming previous experiments we showed in the present study, that the gene transfer of IGF-I cDNA and KGF cDNA individually demonstrated the same effects as previously shown.
TGF-b is a growth factor that has been extensively studied and has multiple functions during the wound healing cascade. 20, 21 The sources of TGF-b are mainly platelets and macrophages and it stimulates keratinocyte migration, chemotaxis for macrophages and fibroblasts, and stimulates fibroblast matrix synthesis and remodeling. 6 In the present study, we showed that during the later phase of wound regeneration TGF-b expression was increased at the wound edge and under the wound bed when compared to normal skin. We showed that IGF-I or KGF or the combination of IGF-I plus KGF cDNA transfer did not have any effect on TGF-b expression. Given the fact that TGF-b is associated with fibrosis in kidney, liver and lung, as well as hypertrophic scaring it is of advantage that IGF-I and KGF did not increase TGF-b. This was also corroborated in the morphological and collagen studies in our study. IGF-I, KGF or the combination of IGF-I plus KGF cDNA did not increase collagen types I or III indicating no pathological scarring during this phase of wound healing.
Wound healing is critical for morbidity and mortality in acute and chronic wounds. In previous studies, we determined the effects of IGF-I or KGF cDNA on wound healing. 5, [9] [10] [11] [12] 22, 23 We showed that after the injection of liposomal cDNA complexes, re-epithelization was significantly improved. In the present study, we found that IGF-I in combination with KGF interacts with other growth factors that are essential for dermal and epidermal regeneration. Local administration of IGF-I plus KGF resulted in increased collagen IV synthesis at the wound edge and under the wound. IGF-I/KGF cDNA did neither lead to increased scaring, nor increased TGF-b expression or increased collagen type I and III expression at the wound site. These findings indicate that IGF-I cDNA leads to a good wound regeneration and closure with no pathological fibrotic effects. IGF-I plus KGF cDNA transfer resulted in accelerated re-epithelization and epidermal regeneration. In observing only differences in neovascularization and VEGF expression, we suggest that IGF-I plus KGF leads to the described improved dermal and epidermal regeneration via VEGF and vascularization. The importance of this finding is that VEGF and neovascularization may play a more important role than previously thought and that VEGF cDNA gene transfer should be included in further studies.
Materials and methods
Forty adult male Sprague-Dawley rats (350-375 g, Harlan, Houston, TX, USA) were placed in wire-bottom cages housed in a temperature-controlled room with a 12 h light-dark cycle. Rats were acclimatized to their environment for 7 days before the blinded study. All animals received similar amounts of a liquid diet of Fresubin (Fresenius Medical Care, Germany) and water ad libitum throughout the study. Each rat received a 30% total body surface area (TBSA) full-thickness scald burn under general anesthesia (pentobarbital 50 mg/kg body weight, Hoechst, Germany) and analgesia (buprenorphin 1 mg/kg body weight, Hoechst, Germany) following a modified procedure as previously described. 24 Rats were anesthetized, shaved, placed in a mole and received a 30% TBSA scald burn (991C hot water contact 10 s to the back). After the thermal injury rats were immediately resuscitated by intra peritoneal injection of Ringer's Lactate (50 ml/kg body weight, Braun Medical, Germany). Thermally injured rats were then randomly divided into one of the four groups: In previous experiments, we found that animals receiving liposomes containing the Lac Z gene represented IGF-I/KGF cDNA increases neovascularization MG Jeschke and DN Herndon a better control compared to animals receiving saline, in having accelerated re-epithelization rates and improved dermal regeneration, and an attenuated acute-phase response. 23 Therefore, we chose in the present study to use liposomes with Lac Z as the control group. The rat IGF-I and KGF cDNA constructs consisted of a cytomegalovirus-driven IGF-I or KGF cDNA plasmid prepared at the UTMB Sealy Center for Molecular Science Recombinant DNA Core Facility. The liposomes were formulated from 1:1 (M/M) 1,2-dimyristyloxypropyl-3-dimethyl-hydroxyl ethyl ammonium bromide and cholesterol suspended in filtered water (Life Technologies, Rockville, MD, USA). This reagent interacts spontaneously with IGF-I cDNA to form the lipid cDNA complex. The dose of 2.2 mg for the IGF-I cDNA, the KGF cDNA and the co-transfection of IGF-I/KGF cDNA was defined in a dose-response study.
Immediately after the thermal injury, each rat received 0.2 ml of the lipoplexes subcutaneously injected at two sites opposite from each other. This was repeated each week for 4 weeks. Mixtures were prepared fresh before injections. Animals were killed by decapitation 5 days after the last injection according to the criteria outlined in the 'Guide for the Care and Use of Laboratory Animals' published by the National Institutes of Health. Skin samples from the back were harvested, fixated in 4% paraformaldehyde, 1% glutaraldehyde, or snap-frozen in liquid nitrogen and stored at À731C for analysis. The skin biopsy encompassed wound bed, wound edge and normal skin, thus being a 2-3 cm long and 1-cm-wide biopsy.
Growth factor expression IGF-I, PDGF, FGF, FGF-7, TGF-b, VEGF
Protein expression in the dermis and epidermis was determined by immunohistochemical methods. Paraffinembedded samples were cut in 4 mm thickness, placed in increasing alcohol expressions and finally in PBS. Protease K (100 mg/ml) was applied at 371C for 30 min. After washing with PBS endogen peroxidases were blocked using methanol-H 2 O 2 for 15 min. The samples were then again washed. Samples were incubated with pig serum (1:5, DAKO X901) for 20 min. After washing the primary antibody rabbit anti-IGF-I (1:10, Peprotech, TEBU, Germany) was applied to the samples and then incubated at 41C twice overnight. After another washing, the secondary antibody DAKO E 431 (biotinylated swine anti-rabbit, 1:300) was incubated for 1 h at 371C followed by another washing. The samples were then incubated with streptavidin (1:300; DAKO P 0397) for 1 h at 371C. The samples were thoroughly washed and diaminobenzidine-hydrogen peroxidase was applied for color development. The counterstaining was performed using Hematoxylin. After placing the samples in increasing alcohol expressions, they were mounted. IGF-I expression was determined by the number of positive cells per HPF and per mm 2 . KGF, VEGF, TGF-b and FGF followed the same staining protocol and information about antibodies are given in Table 1 .
The For VEGF expression we used blood vessels of the small bowel as positive controls. VEGF expression was determined by the number of positive cells per blood vessel. Three observers blinded for treatment counted each sample at three different sites for VEGF-positive cells. Neovascularization was determined by counting blood vessels per HPF in granulation and dermal 1 2 h at 371C followed by another washing. The samples were then incubated with streptavidin (1:300; DAKO P 0397) for 1 h at 371C and again washed. The counterstaining was performed with hematoxylin. After placing the samples in an increasing alcohol row, they were embedded.
Three observers blinded for treatment graded each sample at three different sites for collagen I staining intensity. The observers graded the samples from 0 (low staining)-4 (high staining). The average was formed from the score given by the observers and is depicted in the figures. Collagen III and IV followed the same protocol as above with an antibody against collagen type III or IV, respectively.
Re-epithelization
Re-epithelization was determined by planimetry and by histological examinations. Planimetry was performed as follows: The wound eschar was left intact for the first 28 days and then removed by gentle traction, caution being taken not to disturb or destroy the healing edge along the periphery. After removing the eschar, the animals were placed on a standard surface and the wound area was traced onto acetate sheets along the well-demarcated reepithelized and nonburned interface and the leading edge of the neoepithelium. The areas of these tracings were calculated by computerized planimetry (Sigma Scan and Sigma Plot software, San Rafael, CA, USA). The area of re-epithelization was calculated by the following formula. 
Neoangiogenesis
Neoangiogenesis was determined by counting blood vessel in the granulation tissue. The staining used was H&E. Blood vessels were identified by the typical histomorphological appearance. The observers made sure that blood vessels cut in a longitudinal fashion were not counted twice. Three observers blinded to treatment counted the blood vessels in three different sections of the granulation tissue using a magnification of Â 40 (HPF). Values were averaged and calculated as blood vessels per mm 2 .
Ethics and statistics
These studies were reviewed and approved by the Animal Care and Use Committee (ACUC) of the Regierung der Oberpfalz, Bayern, Germany and IACUC, UTMB at Galveston, Texas assuring that all animal received care according to the criteria outlined in the 'Guide for the Care and Use of Laboratory Animals' published by the National Institutes of Health. The animals were visited twice daily by the group and daily by the ACUC to ensure that animals are not suffering or are in pain. Animals were treated humanely, and pain medication, special nutrition and fluid substitution according to human burn treatment were given. Statistical comparisons were made by analysis of variance and Student's t-test with the Bonferronis' correction were appropriate. Data are expressed as means7s.e.m. Significance was accepted at Po0.05.
